The FDA granted accelerated approval to the first drug to spur growth in kids with the most common form of dwarfism, the agency announced on Friday.
Vosoritide (Voxzogo), a once-daily injectable treatment, is indicated for children 5 years and older with achondroplasia and who still have open growth plates -- in other words, these children still have the potential to grow.
Дай Бог!
__________________
Г.А. Мельниченко
|